Inclusion Criteria : 
  -  Patient has provided written informed consent . 
  -  Patient is 18 years or older . 
  -  Patient is a planned recipient of a living donor kidney transplant . 
  -  Patient is a planned recipient of an ABO blood group - compatible kidney graft . 
  -  Patient is a planned recipient of a kidney graft from a donor that is not HLA ( human leukocyte antigen )  - identical . 
  -  Patient is negative for DSA ( donor - specific antibodies )  . 
  -  WOCBP ( women of child - bearing potential ) must have a negative pregnancy test at inclusion . 
  -  WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 12 weeks after the study in such a manner that the risk of pregnancy is minimized . 
Exclusion Criteria : 
  -  Patient is EBV ( epstein barr virus )  - negative on serology . 
  -  Patient is HIV - positive or suffering from chronic viral hepatitis . 
  -  Patient is CMV ( cytomegalo virus )  - negative and receiving a kidney from a CMV - positive donor . 
  -  Positive T - cell lymphocytotoxic cross match . 
  -  Patient with prior kidney transplant or non - renal solid organ transplant . 
  -  Patient has a known contraindication to any of the protocol - specified treatments . 
  -  Patient had been diagnosed with a malignancy within 5 years prior to study entry , excluding non - metastatic basal or squamous cell carcinoma of the skin . 
  -  Female patients who are breast - feeding . 
  -  Female patients with a positive pregnancy test.